Found 9 matching trials
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067) PHASE3 This is a randomized, parallel-group, placebo-controlled, multi-site, multi...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060) PHASE3 This was an efficacy and safety study of grazoprevir (MK-5172) in combinati...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058) PHASE2 This is a two-part study of grazoprevir (MK-5172) + elbasvir (MK-8742) in J...
Show More Location
Multiple Locations
Learn More & Join Trial
Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079) PHASE2 The purpose of this study is to assess the pharmacokinetics (PK), safety, a...
Show More Location
University of California San Francisco ( Site 0020)
Learn More & Join Trial
An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062) PHASE3 This is a 2-part study. The purpose of Part A is to assess the efficacy and...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052) PHASE2 This study will evaluate the safety and efficacy of combination treatment w...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002) PHASE1 The purpose of this study is to assess the safety, pharmacokinetics (PK) an...
Show More Location
Multiple Locations
Learn More & Join Trial
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065) PHASE3 This is a randomized, multi-site, placebo-controlled trial of a fixed dose ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Combination Regimen Grazoprevir (MK-5172) and Elbasvir (MK-8742) ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035) PHASE2 This is a study of the safety and efficacy of grazoprevir (MK-5172) in comb...
Show More Location
Multiple Locations
Learn More & Join Trial